InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present at Spartan Capital Investor Conference 2025
NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of broad-spectrum antiviral drugs designed to prevent viral escape, announced it will present today, Nov. 3, 2025, at 9:45 a.m. ET at the Spartan Capital Investor Conference in New York City. To view the full press release, visit https://ibn.fm/cnCIM About NanoViricides NanoViricides, Inc. (the "Company") (www.nanoviricides.com) is a publicly traded (NYSE-American, stock symbol NNVC) clinical stage company…